外科转流术及体外开窗分别联合TEVAR治疗累及弓部的Stanford B型主动脉夹层的疗效比较
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

安徽省高等学校科学研究项目(自然科学类)(2022AH051531)


Efficacy comparison of surgical bypass and in vitro fenestration combined with thoracic endovascular aortic repair in treating Stanford type B aortic dissection involving the arch
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨外科转流术及体外开窗分别联合胸主动脉腔内覆膜支架修复术(TEVAR)治疗累及弓部的Stanford B型主动脉夹层(TBAD)的疗效。方法 回顾性分析2018年9月—2022年12月本院收治的118例接受手术治疗的弓部TBAD患者的临床资料,根据治疗方式的不同,分为杂交组(n=83)和开窗组(n=35)。杂交组行外科转流术联合TEVAR治疗,开窗组行体外开窗联合TEVAR治疗。比较两组围手术期情况[手术时间、卧床时长、术后视觉模拟评分法(VAS)评分]、围手术期并发症(内漏、术后感染、脑梗死),治疗前后急性生理和慢性健康状况(APACHEⅡ)评分以及术后6个月、1年主动脉CT造影(CTA)复查情况以及再次手术或介入率、死亡率。结果 杂交组手术时间、卧床时间均长于开窗组(P<0.05),术后VAS评分高于开窗组(P<0.05);两组围手术期并发症发生率比较无明显差异(P>0.05);治疗后,两组APACHEⅡ评分较治疗前均下降(P<0.05),但两组间比较无明显差异(P>0.05);术后6个月、1年,两组支架内血栓形成、Ⅰ型支架内漏发生率比较无明显差异(P>0.05);术后6个月、1年,两组再次手术或介入率及死亡率比较无明显差异(P>0.05)。结论 外科转流术联合TEVAR与体外开窗联合TEVAR对累及弓部的TBAD的疗效相当,但外科转流术联合TEVAR治疗的患者术后恢复时间较长,临床可根据实际情况个体化选择手术方式

    Abstract:

    Objective To compare the efficacy of surgical bypass and in vitro fenestration combined with thoracic endovascular aortic repair (TEVAR) in the treatment of Stanford type B aortic dissection (TBAD) involving the arch. Methods The data of 118 patients with arch TBAD who received surgical treatment in the hospital from September 2018 to December 2022 were retrospectively analyzed. According to the different treatment methods, they were classified into hybrid group and fenestration group. The hybrid group was treated with surgical bypass combined with TEVAR (n=83), while the fenestration group was given in vitro fenestration combined with TEVAR (n=35). The perioperative conditions (surgical time, bedridden duration, postoperative VAS score), perioperative complications (endoleak, postoperative infection, cerebral infarction), Acute Physiology and Chronic Health Evaluation (APACHE II) score before and after treatment, aortic CT angiography (CTA) reexamination at 6 months and 1 year after surgery, re-surgery or intervention rate and death rate were compared between groups. Results The surgical time and bed rest time in hybrid group were longer than those in fenestration group (P<0.05), and the postoperative VAS score was higher than that in fenestration group (P<0.05). There were no significant differences in the incidence rates of perioperative complications between groups (P>0.05). After treatment, the APACHE II score in the two groups was decreased (P<0.05), but there was no obvious difference between groups after treatment (P>0.05). At 6 months and 1 year after surgery, no significant differences were shown in the incidence rates of stent thrombosis and type I endoleak between the two groups (P>0.05). The re-surgery or intervention rate and death rate revealed no significant differences between groups at 6 months and 1 year after surgery (P>0.05). Conclusion Surgical bypass combined with TEVAR and in vitro fenestration combined with TEVAR have the same efficacy on TBAD involving the arch, but surgical bypass combined with TEVAR has a longer postoperative recovery time, and the surgical method can be selected individually according to the actual situation

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-07-21
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司